Literature DB >> 2573631

Distribution of adenosine deaminase complexing protein (ADCP) in human tissues.

W N Dinjens1, J ten Kate, E P van der Linden, J T Wijnen, P M Khan, F T Bosman.   

Abstract

The normal distribution of adenosine deaminase complexing protein (ADCP) in the human body was investigated quantitatively by ADCP-specific radioimmunoassay (RIA) and qualitatively by immunohistochemistry. In these studies we used a specific rabbit anti-human ADCP antiserum. In all 19 investigated tissues, except erythrocytes, ADCP was found by RIA in the soluble and membrane fractions. From all tissues the membrane fractions contained more ADCP (expressed per mg protein) than the soluble fractions. High membrane ADCP concentrations were found in skin, renal cortex, gastrointestinal tract, and prostate. Immunoperoxidase staining confirmed the predominant membrane-associated localization of the protein. In serous sweat glands, convoluted tubules of renal cortex, bile canaliculi, gastrointestinal tract, lung, pancreas, prostate gland, salivary gland, gallbladder, mammary gland, and uterus, ADCP immunoreactivity was found confined to the luminal membranes of the epithelial cells. These data demonstrate that ADCP is present predominantly in exocrine glands and absorptive epithelia. The localization of ADCP at the secretory or absorptive apex of the cells suggests that the function of ADCP is related to the secretory and/or absorptive process.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2573631     DOI: 10.1177/37.12.2573631

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  11 in total

1.  Co-expression of the homologous proteases fibroblast activation protein and dipeptidyl peptidase-IV in the adult human Langerhans islets.

Authors:  Petr Busek; Petr Hrabal; Premysl Fric; Aleksi Sedo
Journal:  Histochem Cell Biol       Date:  2014-11-02       Impact factor: 4.304

2.  New bioinformatics approach to analyze gene expressions and signaling pathways reveals unique purine gene dysregulation profiles that distinguish between CD and UC.

Authors:  Leszek Rybaczyk; Andrew Rozmiarek; Kristin Circle; Iveta Grants; Bradley Needleman; Jacqueline E Wunderlich; Kun Huang; Fievos L Christofi
Journal:  Inflamm Bowel Dis       Date:  2009-07       Impact factor: 5.325

3.  Degranulation of human cytotoxic lymphocytes is a major source of proteolytically active soluble CD26/DPP4.

Authors:  Marcus Lettau; Michelle Dietz; Sarah Vollmers; Fred Armbrust; Christian Peters; Thi Mai Dang; Guranda Chitadze; Dieter Kabelitz; Ottmar Janssen
Journal:  Cell Mol Life Sci       Date:  2019-07-12       Impact factor: 9.261

4.  Adenosine down-regulates the surface expression of dipeptidyl peptidase IV on HT-29 human colorectal carcinoma cells: implications for cancer cell behavior.

Authors:  Ernest Y Tan; Michelle Mujoomdar; Jonathan Blay
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

5.  The binding site of human adenosine deaminase for CD26/Dipeptidyl peptidase IV: the Arg142Gln mutation impairs binding to cd26 but does not cause immune deficiency.

Authors:  E Richard; F X Arredondo-Vega; I Santisteban; S J Kelly; D D Patel; M S Hershfield
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307

6.  Dipeptidyl peptidase IV as a potential target for selective prodrug activation and chemotherapeutic action in cancers.

Authors:  Arik Dahan; Omri Wolk; Peihua Yang; Sachin Mittal; Zhiqian Wu; Christopher P Landowski; Gordon L Amidon
Journal:  Mol Pharm       Date:  2014-11-13       Impact factor: 4.939

7.  Bullous Pemphigoid Associated with the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin in a Patient with Liver Cirrhosis Complicated with Rapidly Progressive Hepatocellular Carcinoma.

Authors:  Masaru Harada; Akitoshi Yoneda; Sanehito Haruyama; Kei Yabuki; Yuichi Honma; Masaaki Hiura; Michihiko Shibata; Hidehiko Matsuoka; Yasuhiro Uchiwa
Journal:  Intern Med       Date:  2017-08-21       Impact factor: 1.271

8.  Anti-inflammatory Effects of Empagliflozin and Gemigliptin on LPS-Stimulated Macrophage via the IKK/NF-κB, MKK7/JNK, and JAK2/STAT1 Signalling Pathways.

Authors:  Nami Lee; Yu Jung Heo; Sung-E Choi; Ja Young Jeon; Seung Jin Han; Dae Jung Kim; Yup Kang; Kwan Woo Lee; Hae Jin Kim
Journal:  J Immunol Res       Date:  2021-06-02       Impact factor: 4.818

9.  A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase.

Authors:  M E Morrison; S Vijayasaradhi; D Engelstein; A P Albino; A N Houghton
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

10.  Changes in Saliva Analytes in Dairy Cows during Peripartum: A Pilot Study.

Authors:  María D Contreras-Aguilar; Pedro J Vallejo-Mateo; Elsa Lamy; Damián Escribano; Jose J Cerón; Fernando Tecles; Camila P Rubio
Journal:  Animals (Basel)       Date:  2021-03-09       Impact factor: 2.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.